Tepotinib Hepatic Impairment Trial

NCT03546608 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment

Interventions

DRUG: Tepotinib

Sponsor

EMD Serono Research & Development Institute, Inc.

Collaborators

[object Object]